TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Uniq Bioresearch Oy
Closing information (x1000 EUR)
| Closing information | 2016/12 | 2015/12 | 2014/12 |
| Turnover |
68
|
41
|
67 |
| Financial expenses |
4
|
0
|
22 |
| Earnings before taxes |
-20
|
-40
|
-51 |
| Total assets |
447
|
571
|
381 |
| Current assets |
16
|
242
|
3 |
| Current liabilities |
218
|
352
|
124 |
| Equity capital |
112
|
152
|
188 |
| - share capital |
37
|
37
|
1,345 |
| Employees (average) | 3 | 2 |
Financial ratios
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Solvency |
25.1%
|
26.6%
|
49.3% |
| Turnover per employee | 23 | 34 | |
| Profit as a percentage of turnover |
-29.4%
|
-97.6%
|
-76.1% |
| Return on assets (ROA) |
-3.6%
|
-7.0%
|
-7.6% |
| Current ratio |
7.3%
|
68.8%
|
2.4% |
| Return on equity (ROE) |
-17.9%
|
-26.3%
|
-27.1% |
| Change turnover |
27
|
-26 | |
| Change turnover % |
66%
|
-39% | |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.